Hennion & Walsh Asset Management, Inc. - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 134 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 5.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
Hennion & Walsh Asset Management, Inc. ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$543
+10.6%
139,574
-3.3%
0.03%
+10.0%
Q4 2022$491
-100.0%
144,353
-47.8%
0.03%
-69.7%
Q3 2022$1,509,000
+16.7%
276,422
-3.6%
0.10%
+23.8%
Q2 2022$1,293,000
-54.5%
286,659
-25.7%
0.08%
-47.0%
Q1 2022$2,844,000
+12.4%
385,837
-2.0%
0.15%
+21.8%
Q4 2021$2,531,000
+6.7%
393,692
-3.4%
0.12%
-0.8%
Q3 2021$2,371,000
-38.9%
407,474
+8.4%
0.12%
-39.6%
Q2 2021$3,878,000
+38.1%
375,798
+40.8%
0.21%
+22.5%
Q1 2021$2,809,000266,9680.17%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders